<font color="red">Atomoxetine_2</font> in autism spectrum disorder : no effects on social functioning ; some beneficial effects on stereotyped behaviors , inappropriate speech , and fear of change . 
<br>
<br> UNLABELLED Abstract Objective : The objective of this study was to investigate the short - term treatment effects of <font color="red">atomoxetine_2</font> on autism spectrum disorder ( ASD ) symptoms in children and adolescents with both ASD and attention - deficit / hyperactivity disorder ( ADHD ) . 
<br> METHODS A total of 97 patients 6 - 17 years of age , with ASD and ADHD , were treated with 1.2 â€‰ mg / kg / day of <font color="red">atomoxetine_2</font> during an 8 week double - blind <font color="red">placebo_2</font> <font color="red">-_2</font> controlled period . Here , we investigated effects on two parent - based secondary outcome measures , the Aberrant Behavior Checklist ( ABC ) and the Children 's Social Behavior Questionnaire ( CSBQ ) . 
<br> RESULTS After 8 weeks of double - blind treatment , <font color="red">atomoxetine_2</font> administration was associated with significant treatment effects on the ABC subscales Hyperactivity , Inappropriate Speech , and Stereotypic Behavior , and on the CSBQ subscale Fear for Changes . 
<br> CONCLUSIONS Our study results indicate no beneficial effects of <font color="red">atomoxetine_1</font> on social functioning . However , <font color="red">atomoxetine_2</font> may ameliorate restricted and stereotyped behaviors and communication . This study has been registered in ClinicalTrials.gov ( www.clinicaltrials.gov ) under registration number NCT00380692 .